Overview

• The Cancer Center Cessation Initiative’s ELEVATE tool embedded in the EHR identified smokers and delivered point-of-care support across a real-world cohort beginning June 2018.
• Among 13,282 patients, 1,725 reported current smoking and 22.1% quit within six months of their initial visit.
• Two-year survival was 85% for those who quit versus 74% for those who continued, with continuing smokers facing a 97% higher risk of death.
• Patients with stage 3–4 disease saw the largest gains, with the 85% survival mark occurring around 540 days for quitters versus 210 days for those who kept smoking.
• Building on these findings, Siteman has implemented the model in 14 affiliated clinics and launched a $1.6 million NCI-supported pragmatic trial across multiple hubs to compare care models.